Medical Properties Trust (MPT) Q3 2024 earnings summary

Executive summary

• Achieved a global settlement with Steward, regaining control of real estate, re-tenanting 17 properties with new operators in five states, and ensuring continuity of patient care during Steward's bankruptcy process.

• Reported a net loss of $801 million for Q3 2024 ($1.34 per share), driven by significant impairment charges and negative fair value adjustments, especially related to Steward and the international joint venture.

• Completed over $2.9 billion in year-to-date asset sales and monetization transactions, including major sales such as the Utah Transaction, Prime, Dignity Health, and UCHealth properties.

• Normalized FFO for Q3 2024 was $0.16 per share, down significantly year-over-year.

• Revenues declined 26% year-over-year for Q3 2024, primarily due to lower cash basis revenues from Steward and Prospect, and property sales.

Financial highlights

• Q3 2024 total revenues: $225.8 million, down from $306.6 million in Q3 2023.

• Net loss attributable to common stockholders: $801 million for Q3 2024 ($1.34/share), compared to net income of $117 million ($0.19/share) in Q3 2023.

• Real estate and other impairment charges: $608 million in Q3 2024, $1.8 billion for the nine months, mainly related to Steward and the international JV.

• Normalized FFO for Q3 2024 was $94 million ($0.16/share), down from $226 million ($0.38/share) year-over-year.

• Paid a quarterly dividend of $0.08 per share in Q3 2024, reduced from $0.15 per share in prior quarters.

Outlook and guidance

• Expect gradual resumption of cash rents from re-tenanted properties in Q1 2025, ramping to $90 million annualized by end of 2025 and $160 million by end of 2026.

• Anticipate total annualized cash rent to exceed $1 billion once all properties are stabilized.

• Confident in ability to address 2025 debt maturities with current liquidity and additional monetization options.

• No material real estate acquisitions expected in the near term; proceeds from PHP Holdings and Connecticut facility sales expected in 2025.

• Dividend limited to $0.08/share per quarter during the Modified Covenant Period.